Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa by Otieno, L, Berkley, JA, Mendoza, YG, Adjei, S, Agbenyega, T, Agnandji, ST, Aide, P, Akoo, P, Ansong, D, Asante, KP, Gesase, S, Hamel, MJ, Hoffman, I, Kaali, S, Kamthunzi, P, Kariuki, S, Kremsner, P, Lanaspa, M, Lell, B, Otieno, GA, Lievens, M, Lusingu, J, Malabeja, A, Masoud, NS, Mtoro, AT, Njuguna, P, Ofori-Anyinam, O, Otieno, W, Owusu-Agyei, S, Schuerman, L, Sorgho, H, Tanner, M, Tinto, H, Valea, I, Vandoolaeghe, P, Sacarlal, J, Oneko, M